Your browser doesn't support javascript.
loading
A population-based prospective study of optic neuritis.
Soelberg, K; Jarius, S; Skejoe, Hpb; Engberg, H; Mehlsen, J J; Nilsson, A C; Madsen, J S; Reindl, M; Wildemann, B; Grauslund, J; Kyvik, K O; Smith, T J; Lillevang, S T; Paul, F; Weinshenker, B G; Asgari, N.
Afiliação
  • Soelberg K; Departments of Regional Health Research and Molecular Medicine, University of Southern Denmark, Odense, Denmark/Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark/Department of Neurology, Slagelse Hospital, Slagelse, Denmark/Department of Neurology, Lillebael
  • Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
  • Skejoe H; Department of Radiology, Aleris-Hamlet Hospital, Copenhagen, Denmark.
  • Engberg H; Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark/Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Mehlsen JJ; Department of Ophthalmology, Lillebaelt Hospital, Vejle, Denmark.
  • Nilsson AC; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Madsen JS; Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, Vejle, Denmark.
  • Reindl M; Clinical Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
  • Grauslund J; Department of Ophthalmology, Odense University Hospital, Odense, Denmark/Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Kyvik KO; Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark/Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Smith TJ; Departments of Ophthalmology & Visual Sciences and Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Lillevang ST; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Paul F; Clinical and Experimental Multiple Sclerosis Research Center and NeuroCure Clinical Research Center, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany/Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité - Universitätsm
  • Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Asgari N; Department of Neurology, Slagelse Hospital, Slagelse, Denmark/Departments of Regional Health Research, Neurobiology and Molecular Medicine, University of Southern Denmark, Odense, Denmark/Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark.
Mult Scler ; 23(14): 1893-1901, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28980518

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neurite Óptica / Progressão da Doença / Esclerose Múltipla Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neurite Óptica / Progressão da Doença / Esclerose Múltipla Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article